Weekly Portfolio Summary
Another painful week is behind me. The portfolio under performed the S&P 500 primarily due to my holdings of NPS Pharma and Citigroup. NPSP continues to be the victim of a biotech sell off and Citigroup has suffered a major setback as the Fed declined their capital distribution plans. For the week ahead, there will be some various government reports that can easily swing the market in any direction in the short-term, however the key factor to my timeline and stocks will be Friday's non-farm jobs report. This report will have to show the right amount of strength to convince markets that the economy is improving and that interest rates can increase. However, it cannot be so strong that rates start to jump. There's a lot of negativity in the market, so it feels like it wouldn't take much for things to start pulling back. Notes: Stock Ratings: 1 = buy at current stock prices, 2 = buy on a 5-10% dip in stock price, 3 = sell on a 5-10% increase in ...